88 related articles for article (PubMed ID: 28932123)
1. Downregulation of DEPTOR inhibits the proliferation, migration, and survival of osteosarcoma through PI3K/Akt/mTOR pathway.
Hu B; Lv X; Gao F; Chen S; Wang S; Qing X; Liu J; Wang B; Shao Z
Onco Targets Ther; 2017; 10():4379-4391. PubMed ID: 28932123
[TBL] [Abstract][Full Text] [Related]
2. The function and mechanism of PSMD14 in promoting progression and resistance to anlotinib in osteosarcoma.
Liu Z; Wang X; Li C; Zhao R
Cancer Cell Int; 2023 Dec; 23(1):309. PubMed ID: 38053170
[TBL] [Abstract][Full Text] [Related]
3. KNTC1 knockdown inhibits the proliferation and migration of osteosarcoma cells by MCM2.
Zhong L; Dong Y; Liu S
Mol Carcinog; 2024 May; ():. PubMed ID: 38818892
[TBL] [Abstract][Full Text] [Related]
4. Reversine inhibits proliferation and induces apoptosis of human osteosarcoma cells through targeting MEK1.
Chen X; Zhong Y; Wang S; Xu S; Chen J; Cheng X; Yang X
J Bone Oncol; 2024 Jun; 46():100601. PubMed ID: 38706714
[TBL] [Abstract][Full Text] [Related]
5. ACSL4 accelerates osteosarcoma progression via modulating TGF-β/Smad2 signaling pathway.
Li X; Chen Q; Zhao D; Tan J; Liao R; Gu Y; Zhu J; Zhang H; Xie J; Chen L
Mol Cell Biochem; 2024 Apr; ():. PubMed ID: 38564125
[TBL] [Abstract][Full Text] [Related]
6. Solute carrier family 35 member A2 regulates mitophagy through the PI3K/AKT/mTOR axis, promoting the proliferation, migration, and invasion of osteosarcoma cells.
Luo X; Zhang J; Guo C; Jiang N; Zhang F; Jiao Q; Xu K; Yang J; Qu G; Lv XB; Zhang Z
Gene; 2024 Mar; 898():148110. PubMed ID: 38151177
[TBL] [Abstract][Full Text] [Related]
7. POLE2 promotes osteosarcoma progression by enhancing the stability of CD44.
Wang B; Hu H; Wang X; Shao Z; Shi D; Wu F; Liu J; Zhang Z; Li J; Xia Z; Liu W; Wu Q
Cell Death Discov; 2024 Apr; 10(1):177. PubMed ID: 38627379
[TBL] [Abstract][Full Text] [Related]
8. Low-energy shock waves promote the cisplatin chemosensitivity of human osteosarcoma MNNG/HOS cells via the P2X7/Akt/mTOR pathway.
Gai N; Ju WN; Yu TC; Qi BC
Ann Med Surg (Lond); 2024 May; 86(5):2665-2670. PubMed ID: 38694312
[TBL] [Abstract][Full Text] [Related]
9. Retraction: Cucurbitacin E inhibits osteosarcoma cells proliferation and invasion through attenuation of PI3K/AKT/mTOR signalling pathway.
Biosci Rep; 2024 Feb; 44(2):. PubMed ID: 38414405
[No Abstract] [Full Text] [Related]
10. Controlled inhibition of methyltransferases using photoswitchable peptidomimetics: towards an epigenetic regulation of leukemia.
Albert L; Xu J; Wan R; Srinivasan V; Dou Y; Vázquez O
Chem Sci; 2017 Jun; 8(6):4612-4618. PubMed ID: 28970883
[TBL] [Abstract][Full Text] [Related]
11. Targeting cartilage EGFR pathway for osteoarthritis treatment.
Wei Y; Luo L; Gui T; Yu F; Yan L; Yao L; Zhong L; Yu W; Han B; Patel JM; Liu JF; Beier F; Levin LS; Nelson C; Shao Z; Han L; Mauck RL; Tsourkas A; Ahn J; Cheng Z; Qin L
Sci Transl Med; 2021 Jan; 13(576):. PubMed ID: 33441426
[TBL] [Abstract][Full Text] [Related]
12. Protein Stability Regulation in Osteosarcoma: The Ubiquitin-like Modifications and Glycosylation as Mediators of Tumor Growth and as Targets for Therapy.
Di Gregorio J; Di Giuseppe L; Terreri S; Rossi M; Battafarano G; Pagliarosi O; Flati V; Del Fattore A
Cells; 2024 Mar; 13(6):. PubMed ID: 38534381
[TBL] [Abstract][Full Text] [Related]
13. PUM1 Promotes Tumor Progression by Activating DEPTOR-Meditated Glycolysis in Gastric Cancer.
Yin S; Liu H; Zhou Z; Xu X; Wang P; Chen W; Deng G; Wang H; Yu H; Gu L; Huo M; Li M; Zeng L; He Y; Zhang C
Adv Sci (Weinh); 2023 Sep; 10(27):e2301190. PubMed ID: 37469018
[TBL] [Abstract][Full Text] [Related]
14. Functional role of MicroRNA/PI3K/AKT axis in osteosarcoma.
Xiang Y; Yang Y; Liu J; Yang X
Front Oncol; 2023; 13():1219211. PubMed ID: 37404761
[TBL] [Abstract][Full Text] [Related]
15. N6-Methyladenosine-Related LncRNAs Are Potential Remodeling Indicators in the Tumor Microenvironment and Prognostic Markers in Osteosarcoma.
Wu Z; Zhang X; Chen D; Li Z; Wu X; Wang J; Deng Y
Front Immunol; 2021; 12():806189. PubMed ID: 35095893
[TBL] [Abstract][Full Text] [Related]
16. The mixed blessing of AMPK signaling in Cancer treatments.
Sadria M; Seo D; Layton AT
BMC Cancer; 2022 Jan; 22(1):105. PubMed ID: 35078427
[TBL] [Abstract][Full Text] [Related]
17. Crosstalk between autophagy inhibitors and endosome-related secretory pathways: a challenge for autophagy-based treatment of solid cancers.
Raudenska M; Balvan J; Masarik M
Mol Cancer; 2021 Oct; 20(1):140. PubMed ID: 34706732
[TBL] [Abstract][Full Text] [Related]
18. An Update on Molecular Pathways Regulating Vasculogenic Mimicry in Human Osteosarcoma and Their Role in Canine Oncology.
Massimini M; Romanucci M; De Maria R; Della Salda L
Front Vet Sci; 2021; 8():722432. PubMed ID: 34631854
[TBL] [Abstract][Full Text] [Related]
19. TGF-β is associated with poor prognosis and promotes osteosarcoma progression
Ma K; Zhang C; Li W
Cell Cycle; 2020 Sep; 19(18):2327-2339. PubMed ID: 32804027
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of long non-coding RNA-AWPPH decreases osteosarcoma cell proliferation, migration and invasion.
Ding W; Wu D; Ji F; Zhang H
Oncol Lett; 2019 Nov; 18(5):5055-5062. PubMed ID: 31612016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
